Home
>
National Drug Code (NDC)
>
AMPYRA
AMPYRA - 10144-427-60 - (Dalfampridine)
Drug Information of AMPYRA
| Product NDC: | 10144-427 |
| Proprietary Name: | AMPYRA |
| Non Proprietary Name: | Dalfampridine |
| Active Ingredient(s): | 10 mg/1 & nbsp; Dalfampridine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of AMPYRA
| Product NDC: | 10144-427 |
| Labeler Name: | Acorda Therapeutics, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022250 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100301 |
Package Information of AMPYRA
| Package NDC: | 10144-427-60 |
| Package Description: | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (10144-427-60) |
NDC Information of AMPYRA
| NDC Code | 10144-427-60 |
| Proprietary Name | AMPYRA |
| Package Description | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (10144-427-60) |
| Product NDC | 10144-427 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Dalfampridine |
| Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20100301 |
| Marketing Category Name | NDA |
| Labeler Name | Acorda Therapeutics, Inc. |
| Substance Name | DALFAMPRIDINE |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |
